Earnings History Data for Revelation Biosciences (REVB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Revelation Biosciences
Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra Acquisition Inc., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2024 | AH | REVB | Revelation Biosciences | 1.00 | -0.84 | -2.84 | 0.00 | 1.03 | 0.21 (25.61%) |
1.01 | 0.19 (23.17%) |
0.70 - 25.26 | 4,820,287 | 390,000 | 15,151,914 | |||
| 10-05-2024 | AH | REVB | Revelation Biosciences | 4.00 | -2.46 | -5.39 | 0.00 | Revelation Biosciences GAAP EPS of -$2.46 [5/10/2024 4:58 PM] |
1.88 | -0.18 (-8.74%) |
2.10 | 0.04 (1.94%) |
1.78 - 39.00 | 130,638 | 30,000 | 1,301 | ||
|
|
||||||||||||||||||
| 22-03-2024 | AH | REVB | Revelation Biosciences | 1.00 | -8.33 | -10.94 | 0.00 | Revelation Biosciences GAAP EPS of -$8.33 [3/22/2024 4:20 PM] |
2.37 | 0.0 (0.00%) |
2.37 | 0.0 (0.00%) |
2.22 - 49.80 | 26,836 | 160,000 | 715 | ||
|
|
||||||||||||||||||
| 11-08-2023 | AH | REVB | Revelation Biosciences | 5.00 | -0.25 | -0.33 | 0.00 | Revelation Biosciences GAAP EPS of -$0.25 [8/11/2023 4:36 PM] |
0.7312 | -0.02 (-2.51%) |
0.73 | -0.02 (-2.67%) |
0.72 - 17.82 | 40,264 | 60,000 | 0 | ||
|
|
||||||||||||||||||
| 30-03-2023 | PM | 4:30 PM ET (Mar 30) |
REVB | Revelation Biosciences | 1.00 | -1.77 | -1.75 | 0.00 | Revelation Biosciences GAAP EPS of -$1.77 [3/31/2023 12:40 AM] |
1.30 | -0.05 (-3.70%) |
1.34 | -0.01 (-0.74%) |
1.27 - 67.90 | 123,715 | 190,000 | 8,131 | |
| 10-11-2022 | AH | REVB | Revelation Biosciences | 5.00 | -0.06 | -0.09 | 0.00 | Revelation Biosciences GAAP EPS of -$0.06 [11/10/2022 10:58 PM] |
0.2184 | 0.0 (-0.77%) |
0.23 | 0.01 (2.54%) |
0.20 - 11.29 | 132,195 | 640,000 | 5,281 | ||